NEO New Oncology is your partner for implementing modern technology for molecular tumor analysis in your lab.
Technology: We offer you an innovative product portfolio that is adapted to laboratory routine procedures. The NEO technology thus supports you in the expansion of molecular tumor analysis for precision oncology or clinical research. Our assays provide comprehensive information on tumor biology for the best possible oncological therapy recommendation and for meaningful research results.
Competence: NEOs expertise lies in the development and continuous optimization of assays for molecular cancer diagnostics and clinical research. Dedicated bioinformaticians develop algorithms that are up-to-date and at par with current scientific findings.
Service: To ensure efficient integration of hybrid capture technology into laboratory routine, you are supported by an experienced team. Our team is available on short notice, in case challenges occur in your routine operations.
Since May 2016, NEO New Oncology has been a subsidiary of Siemens Healthineers.
Learn how Braunschweig Municipal Hospital collaborates with NEO New Oncology.
Do you want to learn more about molecular tumor analysis with NEOonsite?
Write us an e-mail: email@example.com